Efficacy of orlistat in overweight and obese patients with metabolic syndrome and its effects on the risk of coronary heart disease

被引：0

作者：

Caterson, I

Guy-Grand, B

Hill, J

机构：

[1] Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia

[2] Hop Hotel Dieu, Serv Med & Nutr, Paris, France

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A14 / A15

页数：2

共 50 条

[1] Effect of orlistat on coronary heart disease risk in obese patients with hypertension and/or hyperlipidaemia
Lindgärde, F
[J]. EUROPEAN HEART JOURNAL, 2000, 21 : 438 - 438
[2] Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndrome
Filippatos, TD
Kiortsis, DN
Tselepis, AD
Athyros, V
Elisaf, MS
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 107 - 107
[3] Orlistat improves all components of the metabolic syndrome in overweight and obese patients on two diets
Jacob, S
Ziegler, O
Toplak, H
[J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S154 - S154
[4] Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli study
Filippatos, T. D.
Kiortsis, D. N.
Gazi, I.
Liberopoulos, E. N.
Georgoula, M.
Elisaf, M. S.
Tselepis, A. D.
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 553 - 553
[5] Improvement of glycemic control with orlistat in overweight and obese patients with metabolic syndrome and type 2 diabetes
Hollander, P
Rissanen, A
Rabbia, M
Hauptman, J
Boldrin, M
[J]. DIABETES, 2003, 52 : A557 - A557
[6] Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study
Filippatos, TD
Kiortsis, DN
Liberopoulos, EN
Georgoula, M
Mikhailidis, DP
Elisaf, MS
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 1997 - 2006
[7] Efficacy of orlistat in overweight or obese patients with type 2 diabetes in Sweden
Berne, C
[J]. DIABETES, 2003, 52 : A556 - A556
[8] Heart Disease Risk and Self-efficacy in Overweight and Obese Adults
Imes, Christopher C.
Novosel, Lorraine M.
Burke, Lora E.
[J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (10): : 710 - 716
[9] The effect of orlistat on body weight and coronary heart disease risk profile in obese patients:: The Swedish Multimorbidity Study
Lindgärde, F
[J]. JOURNAL OF INTERNAL MEDICINE, 2000, 248 (03) : 245 - 254
[10] Metabolic syndrome: frequency of its components and global risk for coronary heart disease
Ignacio Coniglio, Raul
Nellem, Jorge
Sibechi, Norberto
Colombo, Osvaldo
[J]. ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2011, 45 (03): : 413 - 421

← 1 2 3 4 5 →